(19)
(11) EP 1 265 905 A1

(12)

(43) Date of publication:
18.12.2002 Bulletin 2002/51

(21) Application number: 01916312.0

(22) Date of filing: 01.03.2001
(51) International Patent Classification (IPC)7C07F 9/02
(86) International application number:
PCT/US0106/555
(87) International publication number:
WO 0106/4691 (07.09.2001 Gazette 2001/36)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 01.03.2000 US 186182 P

(71) Applicant: SmithKline Beecham Corporation
Philadelphia, PA 19103 (US)

(72) Inventors:
  • PALOVICH, Michael, R.
    Norristown, PA 19403 (US)
  • WEINSTOCK, Joseph
    Wayne, PA 19087 (US)
  • WIDDOWSON, Katherine, L.
    King of Prussia, PA 19406 (US)

(74) Representative: Quillin, Helen Kaye 
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) IL-8 RECEPTOR ANTAGONISTS